Search / Trial NCT06223945

Thrombohemorrhagic Complications of COVID-19

Launched by VOLGOGRAD STATE MEDICAL UNIVERSITY · Jan 24, 2024

Trial Information

Current as of December 21, 2024

Active, not recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with thrombohemorrhagic complications who were treated in a covid hospital
  • Exclusion Criteria:
  • Cancer patients
  • Patients who had thrombohemorrhagic disorders before admission to the hospital
  • Pregnant women
  • Patients receiving routine anticoagulant and antiplatelet therapy before admission to the hospital

Trial Officials

Viktor Mikhin

Study Chair

Volgograd State Medical University

About Volgograd State Medical University

Volgograd State Medical University is a prestigious educational and research institution dedicated to advancing medical science and healthcare. Located in Volgograd, Russia, the university is renowned for its commitment to clinical excellence, innovative research, and the training of skilled healthcare professionals. As a clinical trial sponsor, Volgograd State Medical University plays a pivotal role in conducting rigorous and ethical clinical research, contributing to the development of new therapies and improving patient outcomes. The university collaborates with various stakeholders in the medical field to ensure the highest standards of scientific integrity and patient safety in all its research initiatives.

Locations

Volgograd, , Russian Federation

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0